Using adoptive transfer of established Pten+/−Eμ-Myc and Eμ-Myc/eIF4E lymphoma cells, Bordeleau et al.[105], demonstrated that silvestrol was inactive when tested alone, but did enhance anti-lymphoma activity of doxorubicin. This evidence concerns the gene PTEN and lymphoma.